Mesothelioma not associated with asbestos exposure

Archives of Pathology and Laboratory Medicine

Volumn 136, Issue 3, 2012, Pages 262-267

  Jasani, Bharat ^a   Gibbs, Allen ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; ERIONITE; ZEOLITE;

ARTICLE; COCARCINOGENESIS; ENVIRONMENTAL EXPOSURE; HUMAN; MESOTHELIOMA; PHYSIOLOGY; PLEURA TUMOR; POLYOMAVIRUS INFECTION; SIMIAN VIRUS 40; VIROLOGY; VIRUS INFECTION;

ASBESTOS; COCARCINOGENESIS; ENVIRONMENTAL EXPOSURE; HUMANS; MESOTHELIOMA; PLEURAL NEOPLASMS; POLYOMAVIRUS INFECTIONS; SIMIAN VIRUS 40; TUMOR VIRUS INFECTIONS; ZEOLITES;

EID: 84858021002     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0039-RA     Document Type: Article

References (99)

1. Spirtas R, Heineman EF, Bernstein L, et al. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med. 1994;51(12):804-811. (Pubitemid 24368130)
2. Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J. Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer. 2009;100(7):1175-1183.
3. McDonald JC, McDonald AD. Mesothelioma: is there a background? In: Jaurand M-C, Bignon J, eds. The Mesothelial Cell and Mesothelioma. New York, NY: Marcel Dekker; 1994:37-45.
4. Health Effects Institute-Asbestos Research (HEI-AR). Asbestos in Public and Commercial Buildings. Cambridge, MA: Health Effects Institute;1991.
5. Price B, Ware A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol. 2004;159(2):107-112. (Pubitemid 38082517)
6. Baris YI, Sahin AA, Ozesmi M, et al. An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgup in Anatolia. Thorax. 1978;33(2):181-192. (Pubitemid 8333490)
7. Artvinli M, Baris YI. Malignant mesotheliomas in a small village in the Anatolian region of Turkey: an epidemiologic study. J Natl Cancer Inst. 1979; 63(1):17-22. (Pubitemid 9206184)
8. Baris YI. Pleural mesotheliomas and asbestos pleurisies due to environmental asbestos exposure in Turkey: an analysis of 120 cases. Hacettepe Bull Med Surg. 1975;8:165-185. (Pubitemid 8121268)
9. Dogan AU. Malignant mesothelioma and erionite. In: Pass HI, Vogelzang N, Carbone M, eds. Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies. New York, NY: Springer; 2005:242-258.
10. Elmes PC. Fibrous minerals and health. J Geol Soc London. 1980;137(5): 525-533.
11. Pooley FD. Evaluation of fiber samples taken from the vicinity of two villages in Turkey. In: Lemen R, Dement JM, eds. Dusts and Disease: Occupational and Environmental Exposures to Selected Fibrous and Particulate Dusts. Park Forest South, IL: Pathotox Publishing; 1979;41-44.
12. Sebastien P, Gaudichet A, Bignon J, Baris YI. Zeolite bodies in human lungs from Turkey. Lab Invest. 1981;44(5):420-425. (Pubitemid 11105373)
13. Dumortier P, Coplu L, Broucke I, et al. Erionite bodies and fibres in bronchoalveolar lavage fluid (BALF) of residents from Tuzkoy, Cappadocia, Turkey. Occup Environ Med. 2001;58(4):261-266. (Pubitemid 32240980)
14. Sebastien P, Gaudichet A, Bignon J, Baris YI. Ferruginous bodies in sputum as an indication of exposure to airborne mineral fibres in the mesothelioma villages of Cappadocia. Arch Environ Health. 1981;39(1):18-23. (Pubitemid 14140552)
15. Wagner JC, Skidmore JW, Hill RJ, Griffiths DM. Erionite exposure and mesotheliomas in rats. Br J Cancer. 1985;51(5):727-730. (Pubitemid 15095754)
16. Suzuki Y, Kohyama N. Malignant mesothelioma induced by asbestos and zeolite in the mouse peritoneal cavity. Environ Res. 1984;35(1):277-292.
17. Carthew P, Hill RJ, Edwards RE, Lee PN. Intrapleural administration of fibres induces mesothelioma in rats in the same relative order of hazard as occurs in man after exposure. Hum Exp Toxicol. 1992;11(6):530-534. (Pubitemid 23023519)
18. Coffin DL, Peters SE, Palekar LD, Stahel EP. A study of the biological activity of erionite in relation to its chemical and structural characteristics. In: Wehner AP, Felton D-L, eds. Biological Interaction of Inhaled Mineral Fibers and Cigarette Smoke: International Symposium/Workshop Papers. Columbus, OH: Battelle Press; 1989.
19. Baris YI, Saracci R, Simonato L, Skidmore JW, Artvinli M. Malignant mesothelioma and radiological chest abnormalities in two villages in Central Turkey: an epidemiological and environmental investigation. Lancet. 1981; 1(8227):984-987. (Pubitemid 11154973)
20. Baris I, Simonato L, Artvinli M, et al. Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: a four-year study in the Cappadocian region of Turkey. Int J Cancer. 1987;39(1):10-17. (Pubitemid 17233821)
21. Baris YI, Grandjean P. Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeolite. J Natl Cancer Inst. 2006;98(6): 414-417.
22. Roushdy-Hammady I, Siegel J, Emri S, Testa JR, Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet. 2001;357(9254):444-445. (Pubitemid 32156148)
23. Dogan AU, Baris YI, Dogan M, et al. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res. 2006; 66(10):5063-5068. (Pubitemid 43844927)
24. Saracci R, Simonato L. Familial malignant mesothelioma. Lancet. 2001; 358(9295):1813-1814.
25. Metintas M, Hillerdal G, Metintas S, Dumortier P. Endemic malignant mesothelioma: exposure to erionite is more important than genetic factors. Arch Environ Occup Health. 2010;65(2):86-93.
26. Kliment CR, Clemens K, Oury TD. North american erionite-associated mesothelioma with pleural plaques and pulmonary fibrosis: a case report. Int J Clin Exp Pathol. 2009;2(4):407-410.
27. Dogan AU, Dogan M, Hoskins JA. Erionite series minerals: mineralogical and carcinogenic properties. Environ Geochem Health. 2008;30(4):367-381.
28. De Pablo-Galan L, de Lourdes Chavez-Garcia M, Cruz-Sanchez M. Sedimentary zeolites in the Sierra Madre del Sur and Sierra Madre Occidental, Mexico. Revista Mexicana de Ciencias Geológicas. 1996;13:188-200.
29. Paoletti L, Batisti D, Bruno C, et al. Unusually high incidence of malignant pleural mesothelioma in a town of eastern Sicily: an epidemiological and environmental study. Arch Environ Health. 2000;55(6):392-398.
30. Comba P, Gianfagna A, Paoletti L. Pleural mesothelioma cases in Biancavilla are related to a new fluoro-edenite fibrous amphibole. Arch Environ Health. 2003;58(4):229-232. (Pubitemid 37444880)
31. Putzu MG, Bruno C, Zona A, et al. Fluoro-edenitic fibres in the sputum of subjects from Biancavilla (Sicily): a pilot study. Environ Health. 2006;5:20.
32. DeNardo P, Bruni B, Paoletti L, Pasetto R, Sirianni B. Pulmonary fibre burden in sheep living in the Biancavilla area (Sicily): preliminary results. Sci Total Environ. 2004;325(1-3):51-58. (Pubitemid 38622275)
33. Newman RH. Fine biogenic silica fibres in sugar cane: a possible hazard. Ann Occup Hyg. 1986;30(3):365-370. (Pubitemid 16023342)
34. Sinks T, Goodman MT, Kolonel LN, Anderson B. A case-control study of mesothelioma and employment in the Hawaii sugarcane industry. Epidemiology. 1994;5(4):466-468. (Pubitemid 24197064)
35. Donaldson K, Murphy FA, Duffin R, Poland CA. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol. 2010;7:5-21.
36. Jaurand M-C F, Renier A, Daubriac J. Mesothelioma: do asbestos and carbon nanotubes pose the same health risk? Part Fibre Toxicol. 2009;6:16-29.
37. Poland CA, Duffin R, Kinloch I, et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 2008;3(7):423-428.
38. Takagi A, Hirose A, Nishimura T, et al. Induction of mesothelioma in p53 +/2 mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci. 2008;33(1):105-116. (Pubitemid 351340768)
39. Sakamoto Y, Nakae D, Fukumori N, et al. Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats. J Toxicol Sci. 2009;34(1):65-76.
40. Dahlgren S. Effects of locally deposited colloidal thorium dioxide. Ann N Y Acad Sci. 1967;145(3):786-790.
41. Antman KH, Corson JM, Li FP, et al. Malignant mesothelioma following radiation exposure. J Clin Oncol. 1983;1(11):695-700. (Pubitemid 14202068)
42. Anderson KA, Hurley WC, Hurley BT, Ohrt DW. Malignant pleural mesothelioma following radiotherapy in a 16-year-old boy. Cancer. 1985;56(2): 273-276. (Pubitemid 15031646)
43. Austin MB, Fechner RE, Roggli VL. Pleural malignant mesothelioma following Wilms' tumor. Am J Clin Pathol. 1986;86(2):227-230. (Pubitemid 16072304)
44. Cavazza A, Travis LB, Travis WD, et al. Post-irradiation malignant mesothelioma. Cancer. 1996;77(7):1379-1385. (Pubitemid 26102340)
45. Gilks B, Hegedus C, Freeman H, Fratkin L, Churg A. Malignant peritoneal mesothelioma after remote abdominal radiation. Cancer. 1988;61(10):2019-2021.
46. Maurer R, Egloff B. Malignant peritoneal mesothelioma after cholangiog-raphy with thorotrast. Cancer. 1975;36(4):1381-1385.
47. Shannon VR, Nesbitt JC, Libshitz HI. Malignant pleural mesothelioma after radiation therapy for breast cancer: a report of two additional patients. Cancer. 1995;76(3):437-441.
48. Stey C, Landolt-Weber U, Vetter W, Sauter C, Marincek B. Malignant peritoneal mesothelioma after Thorotrast exposure. Am J Clin Oncol. 1995;18(4): 313-317.
49. Small GR, Nicolson M, Buchan K, Broadhurst P. Pericardial malignant mesothelioma: a latent complication of radiotherapy? Eur J Cardiothorac Surg. 2008;33(4):745-747.
50. Goodman JE, Nascarella MA, Valberg PA. Ionizing radiation: a risk factor for mesothelioma. Cancer Causes Control. 2009;20(8):1237-1254.
51. Ishikawa Y, Mori T, Machinami R. Lack of apparent excess of malignant mesothelioma but increased overall malignancies of peritoneal cavity in Japanese autopsies with Thorotrast injection into blood vessels. J Cancer Res Clin Oncol. 1995;121(9-10):567-570.
52. Andersson M, Wallin H, Jonsson M, et al. Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 status. Int J Cancer. 1995;63(3):330-336.
53. Travis LB, Land CE, Andersson M, et al. Mortality after cerebral angiography with or without radioactive Thorotrast: an international cohort of 3,143 two-year survivors. Radiat Res. 2001;156(2):136-150. (Pubitemid 32701175)
54. Travis LB, Hauptmann M, Gaul LK, et al. Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast. Radiat Res. 2003;160(6):691-706. (Pubitemid 37521713)
55. van Kaick G, Dalheimer A, Hornik S, et al. The german thorotrast study: recent results and assessment of risks. Radiat Res. 1999;152(6 suppl):S64-S71.
56. Witherby SM, Butnor KJ, Grunberg SM. Malignant mesothelioma following thoracic radiotherapy for lung cancer. Lung Cancer. 2007;57(3):410-413. (Pubitemid 47285421)
57. Neugut AI, Ahsan H, Antman KH. Incidence of malignant pleural mesothelioma after thoracic radiotherapy. Cancer. 1997;80(5):948-950. (Pubitemid 27360477)
58. Teta MJ, Lau E, Sceurman BK, Wagner ME. Therapeutic radiation for lymphoma: risk of malignant mesothelioma. Cancer. 2007;109(7):1432-1438. (Pubitemid 46466572)
59. Hodgson DC, Gilbert ES, Dores GM, et al. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol. 2007;25(12): 1489-1497. (Pubitemid 46759253)
60. Tward JD, Wendland MM, Shrieve DC, Szabo A, Gaffney DK. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer. 2006;107(1):108-115. (Pubitemid 43939037)
61. Travis LB, Fossa SD, Schonfeld SJ, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst. 2005; 97(18):1354-1365. (Pubitemid 41487803)
62. Brown LM, Chen BE, Pfeiffer RM, et al. Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res Treat. 2007;106(3):439-451. (Pubitemid 350029686)
63. Deutsch M, Land SR, Begovic M, Cecchini R, Wolmark N. An association between postoperative radiotherapy for primary breast cancer in 11 National Surgical Adjuvant Breast and Bowel Project (NSABP) studies and the subsequent appearance of pleural mesothelioma. Am J Clin Oncol. 2007;30(3):294-296. (Pubitemid 46884151)
64. De Bruin ML, Burgers JA, Baas P, et al. Malignant mesothelioma after radiation treatment for Hodgkin lymphoma. Blood. 2009;113(16):3679-3681.
65. Stanton MF, Stewart SE, Eddy BE, Blackwell RH. Oncogenic effect of tissue-culture preparations of polyoma virus on fetal mice. J Natl Cancer Inst. 1959;23:1441-1475.
66. Rabson AS, Branigan WJ, Legallais FY. Lung tumors produced by intratracheal inoculation of polyoma virus in Syrian hamsters. J Natl Cancer Inst. 1960;25:937-965.
67. Chabot JF, Beard D, Langlois AJ, Beard JW. Mesotheliomas of peritoneum, epicardium, and pericardium induced by strain MC29 avian leukosis virus. Cancer Res. 1970;30(5):1287-1308.
68. Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am J Pathol. 1993;142(5):1524-1533. (Pubitemid 24058139)
69. Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol. 2002;29(1):2-17. (Pubitemid 34163530)
70. Robinson C, van Bruggen I, Segal A, et al. A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent. Cancer Res. 2006;66(22):10786-10794. (Pubitemid 44876974)
71. Kroczynska B, Cutrone R, Bocchetta M, et al. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl Acad Sci U S A. 2006;103(38):14128-14133. (Pubitemid 44452991)
72. Bocchetta M, Di Resta I, Powers A, et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci U S A. 2000;97(18):10214-10219.
73. Hahn WC, Dessain SK, Brooks MW, et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol. 2002;22(7):2111-2123. (Pubitemid 34224619)
74. Bocchetta M, Carbone M. SV40-mediated oncogenesis. In: Pass HI, Vogelzang N, CarboneM, eds. Malignant Mesothelioma: AdvancesinPathogenesis, Diagnosis, and Translational Therapies. New York, NY: Springer; 2005:34-59.
75. Carbone M, Pass HI, Rizzo P, et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene. 1994;9(6):1781-1790. (Pubitemid 24163409)
76. Jasani B, Jones CJ, Radu C, et al. Simian virus 40 detection in human mesothelioma: reliability and significance of the available molecular evidence. Front Biosci. 2001;6:E12-E22.
77. Gazdar AF, Butel JS, Carbone M. SV40 and human tumours: myth, association or causality? Nat Rev Cancer. 2002;2(12):957-964. (Pubitemid 37328897)
78. Manfredi JJ, Dong J, Liu WJ, et al. Evidence against a role for SV40 in human mesothelioma. Cancer Res. 2005;65(7):2602-2609. (Pubitemid 40490058)
79. Poulin DL, DeCaprio JA. Is there a role for SV40 in human cancer? J Clin Oncol. 2006;24(26):4356-4365. (Pubitemid 46630795)
80. Gee GV, Stanifer ML, Christensen BC, et al. SV40 associated miRNAs are not detectable in mesotheliomas. Br J Cancer. 2010;103(6):885-888.
81. Lopez-Rios F, Illei PB, Rusch V, Ladanyi M. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet. 2004;364(9440):1157-1166. (Pubitemid 39296603)
82. Strickler HD. A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens. Cancer Epidemiol Biomarkers Prev. 2001;10(5):523-532.
83. Jasani B, Cristaudo A, Emri SA, et al. Association of SV40 with human tumours. Semin Cancer Biol. 2001;11(1):49-61. (Pubitemid 32222751)
84. Carbone M, Pass HI, Miele L, Bocchetta M. New developments about the association of SV40 with human mesothelioma. Oncogene. 2003;22(33):5173-5180. (Pubitemid 37059598)
85. Salewski H, Bayer TA, Eidhoff U, Preuss U, Weggen S, Scheidtmann KH. Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53. Cancer Res. 1999;59(8):1980-1986. (Pubitemid 29186175)
86. Leithner A, Weinhaeusel A, Windhager R, et al. Absence of SV40 in Austrian tumors correlates with low incidence of mesotheliomas. Cancer Biol Ther. 2002;1(4):375-379.
87. Engels EA, Viscidi RP, Galloway DA, et al. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J Natl Cancer Inst. 2004;96(18):1368-1374. (Pubitemid 39406170)
88. Lowe DB, Shearer MH, Jumper CA, Kennedy RC. SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen. Cell Mol Life Sci. 2007;64(7-8):803-814. (Pubitemid 46597754)
89. Garcea RL, Imperiale MJ. Simian virus 40 infection of humans. J Virol. 2003;77(9):5039-5045. (Pubitemid 36460918)
90. Stratton K, Almario DA, McCormick M. Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer. Washington, DC: The National Academy of Sciences; 2002.
91. Peterson JT Jr, Greenberg SD, Buffler PA. Non-asbestos-related malignant mesothelioma: a review. Cancer. 1984;54(5):951-960. (Pubitemid 14058459)
92. Hueper WC. Experimental studies in metal cancerigenesis, I: nickel cancers in rats. Tex Rep Biol Med. 1952;10(1):167-186.
93. Wagner JC. Experimental production of mesothelial tumours of the pleura by implantation of dusts in laboratory animals. Nature. 1962;196:180-181.
94. Gold C. A primary mesothelioma involving the rectovaginal septum and associated with beryllium. J Pathol Bacteriol. 1967;93(2):435-442.
95. Oels HC, Harrison EG Jr, Carr DT, Bernatz PE. Diffuse malignant mesothelioma of the pleura: a review of 37 cases. Chest. 1971;60(6):564-570.
96. Roviaro GC, Sartori F, Calabro F, Varoli F. The association of pleural mesothelioma and tuberculosis. Am Rev Respir Dis. 1982;126(3):569-571. (Pubitemid 12022930)
97. Hillerdal G, Berg J. Malignant mesothelioma secondary to chronic inflammation and old scars: two new cases and review of the literature. Cancer. 1985;55(9):1968-1972. (Pubitemid 15116955)
98. Riddell RH, Goodman MJ, Moossa AR. Peritoneal malignant mesotheli-oma in a patient with recurrent peritonitis. Cancer. 1981;48(1):134-139. (Pubitemid 11064389)
99. Livneh A, Langevitz P, Pras M. Pulmonary associations in familial Mediterranean fever. Curr Opin Pulm Med. 1999;5(5):326-331.